DICOM PS3.16 2021d - Content Mapping Resource

CID 6029 Recommended Follow-up from BI-RADS® (Current)
Prev | B DCMR Context Groups (Normative) | Next

## CID 6029 Recommended Follow-up from BI-RADS®

### Note

From BI-RADS®

Resources:

  HTML | FHIR JSON | FHIR XML | IHE SVS XML

Type:

  Extensible

Version:

  20160314

UID:

  1.2.840.10008.6.1.359

Table CID 6029. Recommended Follow-up from BI-RADS®

Coding Scheme Designator | Code Value | Code Meaning | SNOMED-RT ID | UMLS Concept Unique ID
--- | --- | --- | --- | ---
DCM | 111135 | Additional projections |  |
SCT | 399163009 | Magnification views | R-102D6 | C1302233
SCT | 399055006 | Spot compression | R-102D7 | C1302185
DCM | 111136 | Spot magnification view(s) |  |
SCT | 16310003 | Diagnostic ultrasonography | P5-B0000 | C0041618
DCM | 111138 | Old films for comparison |  |
SCT | 18102001 | Mammary ductogram | P5-40060 | C0203033
DCM | 111140 | Normal interval follow-up |  |
DCM | 111141 | Any decision to biopsy should be based on clinical assessment |  |
DCM | 111142 | Follow-up at short interval (1-11 months) |  |
DCM | 111143 | Biopsy should be considered |  |
DCM | 111144 | Needle localization and biopsy |  |
DCM | 111145 | Histology using core biopsy |  |
DCM | 111146 | Suggestive of malignancy - take appropriate action |  |
DCM | 111147 | Cytologic analysis |  |
DCM | 111148 | Biopsy should be strongly considered |  |
DCM | 111149 | Highly suggestive of malignancy - take appropriate action |  |
DCM | 111122 | Known biopsy proven malignancy - take appropriate action |  |
SCT | 241615005 | MRI of breast | P5-0900D | C0344104

Prev | Up | Next
CID 6028 Mammography Recommended Follow-up | Home | CID 6030 Mammography Pathology Codes

DICOM PS3.16 2021d - Content Mapping Resource